|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 September 2001, Vol. 98, No. 5, pp. 1585-1593
TRANSFUSION MEDICINE
Genomic analysis of clinical samples with serologic ABO blood
grouping discrepancies: identification of 15 novel A and B subgroup
alleles
Martin L. Olsson,
Nidal M. Irshaid,
Bahram Hosseini-Maaf,
Åsa Hellberg,
Marilyn K. Moulds,
Hannele Sareneva, and
M. Alan Chester
From the Blood Centre, University Hospital, Lund,
Sweden; Department of Transfusion Medicine, Institute of Laboratory
Medicine, Lund University, Sweden; Immucor/Gamma Reference
Laboratories, Atlanta, GA, and Houston, TX; and Red Cross Blood
Transfusion Service, Helsinki, Finland.
Since the cloning in 1990 of complementary DNA corresponding to
messenger RNA transcribed at the blood group ABO locus, polymorphisms and phenotype-genotype correlations have been reported by several investigators. Exons 6 and 7, constituting 77% of the gene, have been
analyzed previously in samples with variant phenotypes but for many
subgroups the molecular basis remains unknown. This study analyzed 324 blood samples involved in ABO grouping discrepancies and determined
their ABO genotype. Samples from individuals found to have
known subgroup alleles (n = 53), acquired ABO phenotypes associated
with different medical conditions (n = 65), probable chimerism
(n = 3), and common red blood cell phenotypes (n = 109) were
evaluated by ABO genotype screening only. Other samples
(n = 94) from apparently healthy donors with weak expression of A or
B antigens were considered potential subgroup samples without known
molecular background. The full coding region (exons 1-7) and 2 proposed
regulatory regions of the ABO gene were sequenced in
selected A (n = 22) or B (n = 12) subgroup samples. Fifteen novel
ABO subgroup alleles were identified, 2 of which are the first examples of mutations outside exon 7 associated with weak subgroups. Each allele was characterized by a missense or nonsense mutation for which screening by allele-specific primer polymerase chain
reaction was performed. The novel mutations were encountered in 28 of
the remaining 60 A and B subgroup samples but not among normal donors.
As a result of this study, the number of definable alleles associated
with weak ABO subgroups has increased from the 14 previously published
to 29.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Persson, J. A. Letts, B. Hosseini-Maaf, S. N. Borisova, M. M. Palcic, S. V. Evans, and M. L. Olsson
Structural Effects of Naturally Occurring Human Blood Group B Galactosyltransferase Mutations Adjacent to the DXD Motif
J. Biol. Chem.,
March 30, 2007;
282(13):
9564 - 9570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Sousa, J. M. Anicchino-Bizzacchi, M. F. Locatelli, V. Castro, and M. L. Barjas-Castro
The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor
Haematologica,
February 1, 2007;
92(2):
236 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. W. Cooling, K. Kelly, J. Barton, D. Hwang, T. A. W. Koerner, and J. D. Olson
Determinants of ABH expression on human blood platelets
Blood,
April 15, 2005;
105(8):
3356 - 3364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-H. Deng, Q. Yu, Y.-L. Lian, G.-G. Wu, Y.-Q. Su, and X. Zhang
Identification of a Novel B Variant Allele at the ABO Locus in Chinese Han Individuals with B Subgroup
Ann. Clin. Lab. Sci.,
January 1, 2005;
35(3):
265 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dabelsteen and S. Gao
ABO Blood-group Antigens in Oral Cancer
Journal of Dental Research,
January 1, 2005;
84(1):
21 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Seltsam, M. Hallensleben, A. Kollmann, and R. Blasczyk
The nature of diversity and diversification at the ABO locus
Blood,
October 15, 2003;
102(8):
3035 - 3042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hellberg, J. Poole, and M. L. Olsson
Molecular Basis of the Globoside-deficient Pk Blood Group Phenotype. IDENTIFICATION OF FOUR INACTIVATING MUTATIONS IN THE UDP-N-ACETYLGALACTOSAMINE: GLOBOTRIAOSYLCERAMIDE 3-beta -N-ACETYLGALACTOSAMINYLTRANSFERASE GENE
J. Biol. Chem.,
August 9, 2002;
277(33):
29455 - 29459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-C. Yu, Y.-C. Twu, M.-L. Chou, C.-Y. Chang, C.-Y. Wu, and M. Lin
Molecular genetic analysis for the B3 allele
Blood,
July 30, 2002;
100(4):
1490 - 1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|